Hybrid delta-sigma ADC
    171.
    发明授权
    Hybrid delta-sigma ADC 有权
    混合Δ-ΣADC

    公开(公告)号:US07889108B2

    公开(公告)日:2011-02-15

    申请号:US12436813

    申请日:2009-05-07

    IPC分类号: H03M3/00

    摘要: A hybrid delta sigma ADC architecture and method is disclosed to implement a high-resolution delta-sigma modulator with a single-bit output. The system contains a low-order multi-bit analog noise-shaping loop, followed by a high-order single-bit digital modulator. The combination simplifies the analog modulator, and allows the use of most of the full-scale input range.

    摘要翻译: 公开了混合ΔΣADC结构和方法来实现具有单比特输出的高分辨率Δ-Σ调制器。 该系统包含一个低阶多位模拟噪声整形环路,其次是高阶单位数字调制器。 该组合简化了模拟调制器,并允许使用大多数满量程输入范围。

    Multi-code correlation architecture for use in software-defined radio systems
    172.
    发明授权
    Multi-code correlation architecture for use in software-defined radio systems 有权
    用于软件定义无线电系统的多码相关架构

    公开(公告)号:US07864832B2

    公开(公告)日:2011-01-04

    申请号:US11501577

    申请日:2006-08-09

    申请人: Eran Pisek Yan Wang

    发明人: Eran Pisek Yan Wang

    IPC分类号: H04B1/00

    摘要: A reconfigurable multi-code correlation unit for correlating a sequence of chip samples comprising 1) a memory for storing the chip samples; 2) a plurality of add-subtract cells, each add-subtract cell receiving a plurality of real bits, a, and a plurality of imaginary bits, b, from a first chip sample and storing each real bit, a, and each imaginary bit, b, in a data store; and 3) a plurality of sign select units. Each sign select units receives from one add-subtract cell a plurality of first inputs equal to a sum (a+b) of the real bits, a, and the imaginary bits, b, and a plurality of second inputs equal to a difference (a−b) of the real bits, a, and the imaginary bits, b. Each sign select unit generates a plurality of real outputs and a plurality of imaginary outputs, wherein each of the real and imaginary outputs is equal to one of 1) the sum (a+b) multiplied by one of +1 and −1 and 2) the difference (a−b) multiplied by one of +1 and −1.

    摘要翻译: 一种用于关联芯片样本序列的可重构多码相关单元,包括:1)用于存储芯片样本的存储器; 2)多个加减法单元,每个加减法单元从第一个芯片采样接收多个实数位a和多个虚数位b,并存储每个实数位a和每个虚数位 ,b,在数据存储中; 和3)多个符号选择单元。 每个符号选择单元从一个加减法单元接收多个等于实际比特的和(a + b)的第一输入,以及虚数比特b和等于差的多个第二输入( a-b)的真实位,a和虚位b。 每个符号选择单元产生多个实数输出和多个虚数输出,其中实输出和虚数输出中的每一个等于1)和(a + b)之和乘以+1和-1和2之一 )差(a-b)乘以+1和-1之一。

    CONTROL AND DATA CHANNELS FOR ADVANCED RELAY OPERATION
    173.
    发明申请
    CONTROL AND DATA CHANNELS FOR ADVANCED RELAY OPERATION 有权
    高级继电器操作的控制和数据通道

    公开(公告)号:US20100281323A1

    公开(公告)日:2010-11-04

    申请号:US12732547

    申请日:2010-03-26

    IPC分类号: H04B3/36 H04L1/18 G06F11/14

    摘要: A relay station in a wireless communication system is configured to relay communications between the base station and a plurality of subscriber stations. The relay station includes at least one antenna configured to transmit and receive data and control information. The relay station also includes a controller coupled to the antenna. The controller is configured to transmit control information to a subscriber station during a first set of symbols in a relay station to subscriber station (RS-to-SS) subframe. The controller also switches the antenna to a receive mode; and receives control information during a second set of symbols in the RS-to-SS subframe.

    摘要翻译: 无线通信系统中的中继站被配置为中继基站与多个用户台之间的通信。 中继站包括至少一个配置成发送和接收数据和控制信息的天线。 中继站还包括耦合到天线的控制器。 控制器被配置为在中继站到订户站(RS到SS)子帧的第一组符号期间向用户台发送控制信息。 控制器还将天线切换到接收模式; 并且在RS到SS子帧中的第二组符号期间接收控制信息。

    WATER TREATMENT APPARATUS ADAPTIBLE TO NATURAL WATER ENVIRONMENT
    174.
    发明申请
    WATER TREATMENT APPARATUS ADAPTIBLE TO NATURAL WATER ENVIRONMENT 失效
    水处理设备适应自然水环境

    公开(公告)号:US20100133157A1

    公开(公告)日:2010-06-03

    申请号:US12697744

    申请日:2010-02-01

    申请人: Yongjian Sun Yan Wang

    发明人: Yongjian Sun Yan Wang

    IPC分类号: E02B15/04 C02F1/00

    摘要: A water treatment apparatus includes a first fluid channel that can circulate contaminated water in the water body, a first inlet that draws the contaminated water into the first fluid channel, and an outlet that allows the contaminated water to exit the first fluid channel. A second fluid channel installed with a filter therein can filter contaminated water in the water body to produce a filtered water flow. A fluid transport apparatus can draw the contaminated water through the first fluid channel and the second fluid channel. A flow control system allows water to flow in a predetermined angular range while blocking at least a portion of the remaining angular range in at least one of the first inlet and the outlet to achieve mixing coverage with different aspect ratio. The position of the outlet can be adjusted to optimize the flow rate and pattern.

    摘要翻译: 水处理装置包括可以使水体中的污染水循环的第一流体通道,将污染水吸入第一流体通道的第一入口和允许污染的水离开第一流体通道的出口。 安装有过滤器的第二流体通道可以过滤水体中的污染水以产生过滤的水流。 流体输送装置可以通过第一流体通道和第二流体通道吸收被污染的水。 流量控制系统允许水以预定的角度范围流动,同时阻挡在第一入口和出口中的至少一个中的剩余角度范围的至少一部分,以实现具有不同纵横比的混合覆盖。 出口的位置可以进行调整,以优化流速和图案。

    USE OF COMPOSITION COMPRISING AMLODIPINE IN PREPARING MEDICAMENTS FOR TREATING A LOWER URINARY TRACT DISORDER
    176.
    发明申请
    USE OF COMPOSITION COMPRISING AMLODIPINE IN PREPARING MEDICAMENTS FOR TREATING A LOWER URINARY TRACT DISORDER 审中-公开
    在制备药物用于治疗下尿路性疾病的过程中使用包含阿米膦酸的组合物

    公开(公告)号:US20100048644A1

    公开(公告)日:2010-02-25

    申请号:US12447438

    申请日:2007-10-25

    IPC分类号: A61K31/435 A61P13/02

    CPC分类号: A61K31/4422

    摘要: Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder. The lower urinary tract disorder is selected from the group consisting of benign prostate hyperplasia, lower urinary tract syndrome or overactive bladder, especially the lower urinary tract disorder accompanying with hypertension. Amlodipine is any one selected from the group consisting of amlodipine, amlodipine active metabolite, levoamlodipine, pharmaceutically acceptable precursor of amlodipine, or pharmaceutically acceptable salts of amlodipine, amlodipine active metabolite, levoamlodipine, or pharmaceutically acceptable precursor of amlodipine. The pharmaceutical dose of amlodipine is in the range of 1-10 mg. The invention belongs to the field of pharmacy.

    摘要翻译: 包含氨氯地平的组合物在制备用于治疗下尿路疾病的药物中的用途。 下尿路疾病选自良性前列腺增生,下尿路综合征或膀胱过度活动症,特别是伴有高血压的下尿路疾病。 氨氯地平是选自氨氯地平,氨氯地平活性代谢物,左旋氨氯地平,氨氯地平的药学上可接受的前体或氨氯地平的药学上可接受的盐,氨氯地平活性代谢物,左旋氨氯地平或其药学上可接受的氨氯地平前体的任何一种。 氨氯地平的药物剂量范围为1-10mg。 本发明属于药学领域。

    Generic maximum aposteriori probability decoder for use in software-defined radio systems
    177.
    发明授权
    Generic maximum aposteriori probability decoder for use in software-defined radio systems 失效
    用于软件定义无线电系统的通用最大后验概率解码器

    公开(公告)号:US07669105B2

    公开(公告)日:2010-02-23

    申请号:US11501335

    申请日:2006-08-09

    IPC分类号: H03M13/00

    摘要: A reconfigurable maximum a-posteriori probability (MAP) calculation circuit that reuses the arithmetic logic unit (ALU) hardware to calculate forward state metrics (alpha values), backward state metrics (beta values), and extrinsic information (lambda values) for the trellis associated with the MAP algorithm. The alpha, beta and lambda calculations may be performed by the same ALU hardware for both binary code (i.e., WCDMA mode) and duo-binary code (i.e, WiBro mode).

    摘要翻译: 可重构的最大后验概率(MAP)计算电路,其重用算术逻辑单元(ALU)硬件来计算网格的前向状态度量(α值),向后状态度量(β值)和外在信息(λ值) 与MAP算法相关联。 对于二进制码(即WCDMA模式)和二进制二进制码(即WiBro模式),alpha,beta和lambda计算可由相同的ALU硬件来执行。

    Lung-Expressed Polypeptides
    179.
    发明申请
    Lung-Expressed Polypeptides 审中-公开
    肺表达多肽

    公开(公告)号:US20100015047A1

    公开(公告)日:2010-01-21

    申请号:US12551449

    申请日:2009-08-31

    IPC分类号: A61K51/00 A61K39/395

    摘要: Modulators of phosphatidic acid phosphatase type 2C and other polypeptides, highly expressed in cancers as compared to normal tissues, are provided for treatment of proliferative disorders such as cancer. A method is provided for detecting polypeptides that are overexpressed in cancer, whereby antibodies or binding proteins that specifically recognize these molecules are contacted with a patient's bodily fluid. The method provides an early diagnosis of cancer, and can detect recurrence and metastasis following an initial diagnosis. The invention further provides methods of treating cancer with therapeutic agents directed toward these protein and peptide biomarkers.

    摘要翻译: 提供2C型磷脂酸性磷酸酶和与正常组织相比在癌症中高度表达的其它多肽的调节剂用于治疗增殖性疾病如癌症。 提供了用于检测在癌症中过表达的多肽的方法,由此将特异性识别这些分子的抗体或结合蛋白与患者的体液接触。 该方法提供癌症的早期诊断,并且可以在初步诊断后检测复发和转移。 本发明还提供了针对这些蛋白质和肽生物标志物的治疗剂治疗癌症的方法。